Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Maxim Group Downgrades Amryt Pharma to Hold

Maxim Group analyst Jason McCarthy downgrades Amryt Pharma (NASDAQ:AMYT) from Buy to Hold.
byBenzinga Newsdesk
January 10, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Maxim Group analyst Jason McCarthy downgrades Amryt Pharma (NASDAQ:AMYT) from Buy to Hold.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Asia Mixed, European Indexes Slide; Crude Trades Under $78 – Global Markets Today While US Slept

By Akanksha Bakshi
May 31, 6:59 AM
Asian markets showed mixed results on Friday, with Japan's Nikkei 225 and Australia's S&P/ASX 200 closing higher, while China's indices and Hong Kong's Hang Seng ended lower. Despite a rise in Tokyo's core CPI inflation, it remains below the Bank of Japan's target, raising questions about future interest rate hikes.

ADIV